Skip to main content

Investors & media
Overview
Leadership
Board of directors
Contact
Scientific Publications
THB335
Chronic Urticaria
Severe Asthma
Clinical Trials
Overview
Values
Benefits
Open roles

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

November 07, 2024

« back to news page

Contact Us

info@thirdharmonicbio.com

SAN FRANCISCO
(Corporate Headquarters)
1700 Montgomery Street, Suite #210
San Francisco, CA 94111

CAMBRIDGE
130 Prospect Street
Cambridge, MA 02139

Twitter LinkedIn

Privacy policy
Terms of use

© Third Harmonic Bio

logo